# Mycophenolate Mofetil for IgA Nephropathy

> **NCT00863252** · PHASE4 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 40 (actual)

## Conditions studied

- IGA Nephropathy

## Interventions

- **DRUG:** mycophenolate mofetil
- **DRUG:** angiotensin blockade

## Key facts

- **NCT ID:** NCT00863252
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2004-06
- **Final completion:** 2009-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2009-03-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00863252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00863252, "Mycophenolate Mofetil for IgA Nephropathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00863252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*